Congress joins fight over rising cost of EpiPens as Shkreli defends
August 24, 2016 at 11:42 AM EDT
Congress is asking for investigations and answers on Mylan’s increase of EpiPen pricing, while the company blames it on Obamacare.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||